Angiotensin-converting enzyme (ACE) inhibitors can lower median CRP levels and result in better long-term outcome in stroke patients, after controlling for confounding variables and concomitant treatments (Di Napoli and Papa, 2003). Here, CRP is linked to stroke disorder.